Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OSCR
STRONG BUYFLAGOscar Health, Inc. · Healthcare · United States · $8.5B · Avg Vol: $152M/d
Oscar Health has the strongest momentum in this batch at M90, but value at V40 is below the calibrated floor and quality Q53 is thin. Insiders sold 1.44% of shares outstanding, which is separately adverse.
COMPANY DESCRIPTION
Oscar Health, Inc. is a technology-driven health insurance company focused on the individual and family plan market in the United States. The company utilizes a proprietary full-stack technology platform to simplify the member experience, coordinate care, and lower healthcare costs. Oscar's competitive advantage is driven by its high member engagement, personalized virtual care integration, and strategic partnerships with major provider networks.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.1B | 5.9B | 9.2B | 11.7B | 41.6% | 13.3B | 18.5B | 19.8B | 30.0% |
| EPS | -2.85 | -1.22 | 0.10 | -1.69 | — | -0.55 | — | — | — |
| Shares | 216.3M | 229.4M | 250.5M | 297.7M | +37.6% | 265.9M | — | — | — |
| Debt | 298.0M | 298.8M | 299.6M | 430.1M | 13.0% | 482.2M | — | — | — |
| Equity | 890.4M | 804.0M | 1.0B | 977.6M | 3.2% | — | — | — | — |
| Op CF | 380.3M | -272.2M | 978.2M | 1.1B | 42.3% | 2.8B | — | — | — |
| Inv CF | -226.5M | 577.2M | -1.4B | -241.1M | — | — | — | — | — |
| Fin CF | 301.1M | 6.4M | 68.4M | 399.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OSCR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OSCR | Oscar Health, Inc.(you) | $8.5B | 88 | STRONG BUY |
| MOH | Molina Healthcare, Inc. | $10.3B | 76 | BUY |
| HUM.MX | Humana Inc. | $24.1B | 83 | STRONG BUY |
| CNC | Centene Corporation | $31.3B | 92 | STRONG BUY |
| PGNY | Progyny, Inc. | $2.4B | 97 | STRONG BUY |
| CLOV | Clover Health Investments, Corp. | $2.3B | 73 | BUY |
| ELV | Elevance Health, Inc. | $81.9B | 94 | STRONG BUY |
| ALHC | Alignment Healthcare, Inc. | $4.0B | 51 | HOLD |
| CI | The Cigna Group | $76.6B | 97 | STRONG BUY |
| CVS | CVS Health Corporation | $137.5B | 89 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%